Absolutely aug. But my post was responding to why the market is "ignoring" not implying there's a "run of the mill" research grant program for anything that might possibly look like a go.
I stand by my comments. There is a common process. Pharma's have a large budget to target particular types of technology R&D that fits their strategy. This strategy of R&D in the large pharma sector has been around a long time now and is also used in other sectors because it is more cost effective and efficacious for identifying solid opportunities. The process actually is "routine". From their side it's routine. From our side it's pretty exciting. From the market's side it's wait and see because many of these research relationships do not progress.
here, this one even has an interview with Pfizer
https://www.thebalance.com/who-funds-biomedical-research-2663193
- Forums
- ASX - By Stock
- ALA
- Pfizer OTC
Pfizer OTC, page-48
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALA (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.3¢ |
Change
-0.003(1.43%) |
Mkt cap ! $181.3M |
Open | High | Low | Value | Volume |
17.0¢ | 17.3¢ | 16.8¢ | $85.23K | 501.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 214047 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 387479 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 214047 | 0.170 |
15 | 308822 | 0.165 |
10 | 436851 | 0.160 |
7 | 299542 | 0.155 |
5 | 466666 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 387479 | 11 |
0.180 | 526450 | 6 |
0.185 | 1476111 | 14 |
0.190 | 112870 | 6 |
0.195 | 360000 | 3 |
Last trade - 11.55am 24/07/2024 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online